Abstract
Granulomas are organised collection of activated histiocytes induced by a persistent antigen stimulus. A wide variety of antigens encountered by the gastrointestinal tract are of this nature and hence the resulting granulomatous inflammation represents a tissue reaction pattern. The potential causes can be broadly classified as infections or non-infectious immune reactions. There is also a group where a cause is never identified. Granulomas may be of varying morphological appearance, most commonly epithelioid, foreign body type, suppurative and necrotizing. This may provide a clue as to the aetiology; however, in most cases, the cause requires further inquiry. Pathologists may need to cut deeper levels to look for foreign material and apply special stains to look for microorganisms. Pathologists also need to be certain that the process is a true granuloma and not a mimic. The site of occurrence in the gastrointestinal tract and the clinical setting is often paramount in establishing the aetiology. For instance, infections are more likely the cause in developing countries or when there is immunosuppression. Similarly, granulomas in the stomach are usually due to Crohn’s disease; however, it is only rarely the cause of granulomas isolated to the appendix.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
A granuloma is an organised collection of activated macrophages (or histiocytes), the result of a unique chronic inflammatory process to an antigen (or autoantigen) that is persistent or difficult to remove [1]. Many antigens encountered by the luminal gastrointestinal tract have these qualities, and hence granulomas are not infrequently encountered in this organ. The histiocytes in a granuloma are organised as a circumscribed collection with defined boundaries. Two main types of granulomatous reactions are recognised: (1) foreign body type, formed in an attempt to phagocytose relatively inert foreign material (e.g. suture material) and not involving activation of the T cell-mediated immune response, and (2) immune granulomata, developing as a result of a persistent T cell-mediated immune response and activation of both innate and adaptive immune pathways [1, 2]. The exact pathways and relative effect of mediating cytokines vary depending on the inciting antigen and this produces varied morphology. Lymphocytes are a common accompaniment of the histiocytes in a granuloma. Occasionally, other inflammatory cells such as neutrophils and eosinophils are also present, again dependant on the inciting antigen and consequent immune pathway.
Granulomatous inflammation is best viewed as an inflammatory reaction pattern with the defining morphological marker being an organised arrangement of histiocytes—a ‘granuloma’. Granulomas may exhibit a variety of patterns which broadly reflect the underlying aetiology. General types include foreign body type, characterised by multinucleate cells with eccentrically or haphazardly arranged nuclei; epithelioid, characterised by single or multinucleate collections of histiocytes with abundant eosinophilic cytoplasm and ‘foot print’-like nuclei; xanthogranulomatous, characterised by collections of lipid laden macrophages and multinucleate cells; suppurative, with a central zone of neutrophils; and necrotising, with central necrosis that may retain the structure of the underlying necrotic tissue or in the case of tuberculosis related caseous necrosis will be devoid of any structure. Two important subtypes of epithelioid granulomas are also recognised. Sarcoidal granulomas are a form largely devoid of other inflammatory cells and often containing calcified bodies (Schaumann bodies and/or asteroid bodies). Microgranulomas are smaller than usual granulomas with the number of histiocytes averaging 7–18 as against 25–90 [3].
The inciting antigens are best considered for practical purposes under two headings, infectious and non-infectious. In some cases, despite extensive investigation, an identifiable cause may not be found and the term idiopathic granulomatous inflammation is appropriate. Table 1 lists the major aetiologies of granulomas in the gastrointestinal tract.
Approach to granulomas in the gastrointestinal tract
The first issue when presented with a ‘granuloma’ in the gastrointestinal tract is to confirm that the process is indeed a true granuloma. Many normal structures can mimic a granuloma under certain circumstances. for instance the sclerotic germinal centre of a reactive lymphoid follicle and cross-cutting of the pericryptal fibroblast sheath. Inflammation may also alter normal structures such that they might resemble a granuloma. Examples include ganglion cells which undergo hypertrophy and become translocated to the mucosa. Similarly, the muscularis mucosae might be disrupted and appear as a rounded collection of smooth muscle cells (Fig. 1a), and endothelial cells may enlarge and appear clustered. In addition, lesions such as Schwann cell hamartoma (Fig. 1b), perineurioma and elastofibroma can all resemble granuloma in their early development. Pathologists should be vigilant to the possibility of these mimics.
Once confirmed, the next step is to determine the likely cause of the granuloma and therefore the clinical significance. The clinical setting might already indicate the aetiology and no further inquiry is required, for example in follow-up biopsies of established Crohn’s disease or a patient known to have chronic granulomatous disease. The morphology of the granuloma and presence, pattern and type of background inflammation are important to aid identification when the cause is unknown. Table 2 summarises this morphology-based method.
In all cases where the cause is not known, the following approach is recommended. Firstly, look for an inciting cause in the tissue sections. This might be a foreign material (polarise the slide, also consider pneumatosis) (Fig. 2a), a parasite (ensure sufficient levels are cut) (Fig. 2b) or crypt rupture (look for a crypt that is at the edge of the granuloma with mucin extravasation and neutrophil and eosinophil infiltration) (Fig. 2c). Secondly, look for any additional clues, for instance the brown pigment laden macrophages in the non-inflamed bowel of chronic granulomatous disease (Fig. 3b). Thirdly, all cases for which an aetiology remains uncertain should have organism stains (‘bug stains’) performed, at a minimum PAS, ZN and Wade-Fite. If infection is favoured clinically and organisms are not identified by special stains, additional polymerase chain reaction (PCR) studies on paraffin-embedded formalin fixed tissue can be performed for tuberculosis, fungi and Yersinia. Clinical investigations such as stool culture or serology are also potentially helpful.
Finally, and often most importantly, the clinical setting might provide the answer as to the aetiology, and great value is often obtained by discussing the case with the referring clinician. Significant clinical factors that aid in the diagnosis are summarised in Table 3.
Depending of the aetiology, granulomas may be localised to a particular site in the gastrointestinal tract or may occur at several sites.
Specific aetiologies and diseases
Crohn’s disease
Although considered to be a hallmark of this disease, the reported frequency of granulomas in Crohn’s disease varies from only 15 to 60%, with an average detection of 45% [4, 5]. Granulomas are present in 25–40% of Crohn’s disease biopsies at first presentation [6, 7]. Detection is higher in children than adults [7, 8], and the likelihood of finding granulomas increases with the more biopsies taken [4, 6]. Granulomas are more commonly found in resection specimens than mucosal biopsies [4]. It is also recognised that granulomas are more likely to be detected as the length of disease increases [6]. Granulomas developing in Crohn’s disease are in a constant state of development and resolution [8, 9] depending on the immunological state. The findings of a recent meta-analysis conclude that the presence of granulomas in Crohn’s disease is associated with a higher number of recurrences and reoperations and a shorter time to recurrence and reoperation compared to Crohn’s disease without granulomas [5]. However, not all studies have found granulomatous Crohn’s disease to be prognostically significant [8].
Granulomas in Crohn’s disease may occur in all layers of the gastrointestinal tract wall. They may become intimately associated with the mural vasculature [10, 11]. Similarly, they may reside within the muscularis mucosae. A wide variety of patterns including microgranulomas (with limited numbers of histiocytes) [3], sarcoidal type epithelioid granulomas without associated inflammation and sometimes exhibiting Schaumann bodies (Fig. 4a) [12] and epithelioid type with prominent multinucleate histiocytes may be seen. Rarely, there may be focal necrosis or suppuration (see Fig. 4b).
Tuberculosis
Infection by mycobacterium tuberculosis (tuberculosis) remains an important treatable aetiology of granulomatous disease of the gastrointestinal tract with the combined impact of immigration from high risk areas, HIV infection, bacterial multidrug resistance [13] and increasing use of immunomodulators [14] altering the epidemiology. Clinically, radiologically, endoscopically and histologically, this infection may closely resemble Crohn’s disease [15]. Histological features that serve as clues to the possibility of tuberculosis include large coalescing granulomas, the presence of caseous necrosis and tendency for the inflammation to be focal and have submucosal accentuation [16–18]. Basal plasmacytosis and presence of microgranuloma are more typical of Crohn’s disease cases [16, 17]. In general, granulomata of tuberculosis are more readily found compared to Crohn’s disease [16]. Unfortunately, while caseous necrosis is quite specific for gastrointestinal tract tuberculosis, it is found in a minority of cases on biopsy and only about half of cases overall [2, 16, 18]. Furthermore, the sensitivity of Ziehl-Neelsen stain is only approximately 20.5% [19] and formal culture is notoriously slow to yield a result when oftentimes diagnosis and treatment need to be established quickly. PCR performed on paraffin material to confirm the mycobacterium tuberculosis organism is more rapid and has a reported sensitivity of 64.1% [19]. The most useful investigation is serological examination for specific interferon gamma release (QuantiFERON tuberculosis) [20].
Inherited disorders
Several inherited conditions produce granulomas in the gastrointestinal tract. The most common of these is chronic granulomatous disease which can be inherited in both X-linked and autosomal recessive fashion [21]. The former is more common and hence males are more likely affected. Granulomas develop from defective neutrophil function resulting from dysfunction of NADPH oxidase required for the generation of superoxide essential to kill ingested bacterial organisms [21]. The condition typically presents within the first two decades of life and 55–61% of patients with chronic granulomatous disease have granulomas in the gastrointestinal tract [22, 23]. These are often associated with focal inflammation and this occurs throughout the gas intestinal tract but is more commonly seen in the colorectum (Fig. 3a) [22, 23]. The histological pattern may be strikingly similar to Crohn’s disease [23]. A very useful diagnostic pointer is the presence of pigmented macrophages in the mucosa which is seen in up to 75% of patients (Fig. 3b) [22].
Other rare inherited conditions include Hermansky-Pudlak syndrome, an autosomal recessive condition characterised by albinism, skin hyperpigmentation and platelet deficiency. Fewer than 10% of patients develop colonic inflammation; however, this may closely resemble Crohn’s disease by the presence of granulomas and/or fistulas [24]. Similar to chronic granulomatous disease, pigment laden (ceroid) macrophage may be seen in the adjacent mucosa [24]. Blau syndrome is an autosomal dominant condition with multiorgan granuloma formation. Similar to some forms of Crohn’s disease, the immunopathogenesis is via mutation in NOD2 gene, although gastrointestinal tract involvement is relatively uncommon [25].
Sarcoidosis
This common cause of systemic granulomatosis only affects the luminal gastrointestinal tract in 0.1–1.6% of cases [26]. The stomach, in particular the antrum, is most commonly affected with 96% of all digestive tract sarcoidosis involving this site [26, 27]. This is followed by the colon which is involved in approximately in one third of cases [26]. Endoscopic features include ulceration, polyp formation and occasionally stricturing [26, 27]. The granulomas are tight non-necrotising collections of histiocytes typically with minimal or no inflammation (Fig. 5b) unless there is accompanying ulceration. Calcified structures (Schaumann bodies) may be seen within the granulomas and represent a minor clue to diagnosis; however, this feature is not specific (see Crohn’s disease above). Foreign material may also mimic the calcific bodies. The diagnosis of sarcoidosis is usually established by identification of thoracic or other extraintestinal disease and by elevated level of angiotensin-converting enzyme.
Foreign material
The gastrointestinal tract encounters large number foreign bodies both via ingestion and by iatrogenic means (i.e. postsurgical). A characteristic feature is the foreign body giant cell reaction containing multinucleate giant cells with nuclei that are randomly distributed through eosinophilic cytoplasm. The inciting foreign material may be evident in the H&E stain, sometimes after cutting multiple deeper levels, or may become apparent upon polarisation. Well-described foreign materials encountered in the gastrointestinal tract include talc and starch (often in the subserosal region in a post-operative setting) [28], barium [29], suture material [30] and faecal material. A particular form of the latter is the pulse granuloma, most often encountered in the rectum and sometimes forming a mass (‘pseudotumour’) [31]. Histological features include foreign body giant cells with variable amounts of hyaline ribbons and rings, inflammation, calcifications and food particles (see Fig. 2a) [32]. A foreign body giant cell reaction often surrounds parasites and their eggs that invade the stomach or intestinal wall. Most commonly encountered are schistosomiasis [33], enterobius [34] and strongyloides [35] (see Fig. 2b). All may be accompanied by an intense eosinophil reaction sometimes masking the causative organism; hence, multiple deeper levels are always recommended when granulomas and focal eosinophil infiltration are encountered. Parasite-related granulomatous inflammation may be so marked as to cause a polyp or mass lesion [33]. This is often in the rectum with enterobius and schistosomiasis. Serological testing is available to assist in the diagnosis of strongyloides and schistosomiasis [33].
A foreign body giant cell reaction may occur around the gas pockets of pneumatosis in the gastrointestinal tract. In mucosal biopsies, this often occurs in the deep aspect of the specimen, where the inciting gas pocket may not be appreciated. Variable inflammation and crypt disarray can produce a resemblance to Crohn’s disease [36]. Eosinophils can be prominent and further confuse the diagnosis but serve as a clue when the pathologist is cognisant of this condition.
Medications
A medication reaction producing granulomatous inflammation is surprisingly infrequently reported in the luminal gastrointestinal tract in contrast to examples in the liver, skin and lung. There exist sparse case reports [36]; however, our personal experience is that medications are responsible for some cases of either localised or diffuse gastrointestinal tract granulomatosis. In particular, we have seen cases associated with several new immune modulatory drugs (see Fig. 6a, b), although it is unclear whether the granulomas result from an aberrant immune reaction, florid crypt destruction or an infection due to the induced immunodeficiency. Recent reports have affirmed this impression with colonic granulomas being associated with PD1 inhibitor-induced colitis [37].
Vasculitis
Four forms of vasculitis affecting the gastrointestinal tract can be associated with granulomata. Eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome) is a triad of asthma, hypereosinophilia and vasculitis which involves the gastrointestinal tract in approximately one third to one half of patients [2, 38]. The associated vasculitis and eosinophilic infiltrate are a clue to the diagnosis; however, it is the clinical background that establishes the diagnosis. Despite the name granulomata are infrequent [38]. Granulomatosis with polyangitis (Wegener’s granulomatosis) most commonly affects the respiratory tract. Unusually, there is involvement of the gastrointestinal tract. Granulomatous inflammation, vasculitis, extensive ulceration and necrosis are the main histological findings [2, 39]. Behcet’s disease is a multiorgan inflammatory process of presumed immune aetiology that is characterised by recurrent oral and genital ulcerations and manifestations of vasculitis. Intestinal involvement is seen in between 3 and 60% of patients depending on geographic location [40]. The ileocaecal valve is the most involved site and punched out ulcers that appear aphthoid or round are present. Histologically, there is relatively non-specific active chronic inflammation. Characteristic vasculitis is not often identified on mucosal biopsies. Epithelioid granulomata are only rarely encountered, but when seen, the already difficult separation from Crohn’s disease is further exacerbated. Finally, giant cell arteritis may very rarely involve the gastrointestinal tract. The intimate association of the giant cells with a medium-sized muscular artery helps with the diagnosis, although Crohn’s disease is a far more common cause of this pattern in the gastrointestinal tract [41].
Miscellaneous
A small subset of common variable immunodeficiency presents an endoscopic and histological pattern identical to Crohn’s disease with focal inflammation and granulomas [42]. The clinical association of recurrent infections and abnormality in gamma globulin is helpful in establishing the diagnosis. Cord colitis syndrome develops in recipients of umbilical cord blood transplant and is reported to show diffuse gastrointestinal tract granulomata [43]. A variety of neoplasms of the gastrointestinal tract may be associated with granulomatous inflammation generally as an immune reaction to the tumour. A commonly encountered example of this occurs in microsatellite instability—high colorectal carcinoma. Granuloma formation may occur when crypts or glands rupture as a result of any inflammatory process. The best characterised situation is in ulcerative colitis. The main clue to this process is the finding of the granuloma centred on the residual crypt or gland and the presence of some extravasated mucin admixed with neutrophils and eosinophils associated with the granuloma [8, 44, 45]. Deeper levels are very useful in documenting the association with a ruptured crypt [46].
Finally, there is an expanding interest in so-called autoinflammatory granulomatous diseases, which result from dysfunction, often inherited, of genes involved in certain inflammatory pathways, the end result being granulomatous inflammation [47]. Blau syndrome (discussed above) and early onset sarcoidosis are examples, with mutations existing in the NOD2 gene.
Idiopathic
Despite the investigation, some cases of gastrointestinal tract granulomatosis defy explanation. Infection for which the organism cannot be identified is often blamed. Immune dysregulation syndromes such as common variable immunodeficiency should always be considered, because other clinical manifestations may be underappreciated. In some cases, only long-term follow-up can exclude Crohn’s disease.
Specific sites
Granulomatous gastritis
Aetiology common to granulomatous gastritis
• Crohn’s disease |
• Sarcoidosis |
• Helicobacter pylori |
• Non-H. pylori infections |
• Neoplasm-related gastric adenocarcinomas and mucosa-associated lymphoid tissue (MALT) lymphomas |
• Idiopathic |
Granulomatous gastritis is the term given for the presence of granulomas occurring in the stomach. Most cases are associated with chronic inflammation, but the term is still applicable without it. This finding is uncommon, with a reported incidence between 0.08 and 0.35% in gastric biopsies [48–50]. Granulomas may be numerous and dominate the histological pattern. However, more often than not, granulomas are accompanied by other patterns of inflammation, commonly active chronic inflammation, that appear to be the major abnormality.
Granulomatous gastritis is a reaction pattern that has both infective and non-infective causes. The aetiology varies according to geography and ethnicity. For instance in developed countries, the majority of cases are of non-infectious aetiology with the most common cause being Crohn’s disease [49, 50]. This is almost always the cause in children [51]. Meanwhile, worldwide, the most common aetiology of granulomatous gastritis is infection, of which tuberculosis is the most important cause to consider [52].
Crohn’s disease is associated with granulomatous inflammation in the stomach in between 8 and 75% of patients [53, 54]. Up to half of all cases of granulomatous gastritis in developed countries are related to Crohn’s disease [48]. The prevalence appears to be higher in the paediatric age group [51]. Within the stomach, a sub-pattern of focally enhanced gastritis may provide a clue to the diagnosis (Fig. 5a); however, a diffuse pattern with granulomas is occasionally encountered in limited biopsies [7]. Gastric Crohn’s disease is often accompanied by involvement of the other sites of the GI tract; therefore, an important step is to correlate with the finding of biopsies of other sites [7].
Granulomas are found in a variable percentage of H. pylori-infected stomachs. In one study, which accords with our experience, they were identified in 1.1% of H. pylori-containing gastric biopsies [55]. This is in contrast to a Korean study where H. pylori were present in 78% of cases [49]. The granulomas were single and located in the antrum [49]. It is unclear whether H. pylori can be regarded as the aetiology or an incidental finding; however, eradication of H. pylori has been associated with regression of the granulomas [56, 57]. Practically, if a patient has ileal or ileocolonic Crohn’s disease, then any granulomatous gastritis can be regarded as evidence of upper gastrointestinal tract Crohn’s disease regardless of the presence of Helicobacter infection.
In addition to mycobacteria and Helicobacter infection, other infections have been associated with gastric granuloma formation but are quite rare. These include syphilis (tertiary form ‘gumma’), Whipple disease, parasitic infections, such as anisakiasis, schistosomiasis and taeniasis, and invasive fungal infections [58, 59].
Rare causes of granulomas gastritis include sarcoidosis (discussed above; Fig. 5b), medications, e.g. carbimazole [60], and foreign body granulomas due to food or antacids that become impacted in an ulcer or due to suture material [59]. Granulomatous inflammation has been reported in association with several tumours including gastric adenocarcinomas, Langerhans cell histiocytosis and MALT lymphomas [59].
Finally, gastric granulomas develop without obvious aetiology in up to 25% of cases. The term idiopathic granulomatous gastritis is appropriate for these cases that remain of uncertain cause after extensive investigation both clinically and pathologically. Long-term follow-up is important as idiopathic granulomatous gastritis may precede the full spectrum of a specific disease, sarcoidosis or Crohn’s disease in particular, sometimes by many years [59]. Therefore, an initial ‘diagnosis’ of idiopathic granulomatous gastritis should not be regarded as a distinct entity.
Granulomatous ileitis
Aetiology common to granulomatous ileitis
Infectious |
• Tuberculosis |
• Yersinia |
Non-infectious |
• Crohn’s disease |
• Vasculitis—Behcet’s |
• Neoplasm related—lymphoma, adenocarcinoma, neuroendocrine tumour |
Crohn’s disease is by far the most common cause of granulomas in the ileum in developed countries, whereas in underdeveloped countries, the main cause is tuberculosis. The ileum is a preferential site for intestinal tuberculosis because of the high densities of lymphoid aggregates, neutral pH environment and ready absorption of the organisms at this site [61]. Approximately 90% of all intestinal tuberculosis involves the ileum [62]. Distinction from Crohn’s disease is extremely problematic in regions where tuberculosis is endemic. Features that favour Crohn’s disease include the presence of anorectal disease, a longitudinal pattern of ulceration and a cobblestone appearance to the mucosa [13, 15, 18, 62]. Histologically large confluent granuloma and necrosis within the granulomas are rare for Crohn’s disease and should always prompt investigation for tuberculosis. PCR from paraffin-embedded material can aid in the diagnosis.
Yersinia infection is a common mimic of both Crohn’s disease and tuberculosis in the ileum. Yersinia enterocolitica and Yersinia pseudotuberculosis are the most commonly encountered species. They are gram-negative coccobacilli acquired by ingestion of contaminated food. Infection is often self-limited but chronic infections can develop [62]. Infection risk is increased in patients with iron overload disorders. Table 4 provides helpful diagnostic clues.
Granulomatous colitis
Aetiology common to granulomatous colitis
Infectious |
• Systemic forms (tuberculosis, histoplasmosis) |
• GI infections (Salmonella, Yersinia, Campylobacter, parasites) |
• Venereal infections in rectum (syphilis, lymphogranuloma venereum) |
Non-infectious |
• Crohn’s disease |
• Ulcerative colitis (mucin granuloma) |
• Diverticular colitis (syn. diverticular disease-associated colitis) |
• Pneumatosis coli |
• Malignancy related—e.g. granulomatous reaction to microsatellite instability high colorectal carcinoma |
The large intestine is the most common site in which granulomas are identified within the gastrointestinal tract. Crohn’s disease is the most common aetiology. However, a high index of suspicion of other possibilities should always be maintained before making this diagnosis, particularly if the inflammatory changes and granulomata are limited to the large intestine. In particular, granuloma limited to the sigmoid colon can represent an idiosyncratic reaction to the diverticular disease [63]. Furthermore, granulomata limited to the distal rectum, while common in Crohn’s disease, can also be seen with venereal infections in particular syphilis and lymphogranuloma venereum [64]. Patchy active chronic inflammation with granulomata, sometimes numerous, may represent resolving stage ulcerative colitis. Attention should be paid to the association of granulomas to crypts [45].
Foreign body type granulomata occurring at the base of the mucosa in biopsy specimens may represent pneumatosis coli. Associated gas pockets and eosinophil infiltrate are helpful clues for the latter [65]. Bacterial infection by Salmonella or Campylobacter may very rarely produce scattered microgranulomata typically in the setting of an acute inflammatory process with marked cryptitis, crypt abscess formation and mucosal oedema [66].
Granulomatous appendicitis
Aetiological common to granulomatous appendicitis
Infectious |
- Tuberculosis, Yersinia, parasites (enterobius, schistosomiasis) |
Non-infectious |
- Interval appendicitis |
- Crohn’s disease |
- Idiopathic |
Granulomatous appendicitis is an uncommon finding identified in 0.1 to 2.0% of appendicectomy specimens [67, 68]. Cases may present with symptoms and signs of acute appendicitis or the process may be asymptomatic and identified in the appendix removed for other reasons. Granulomatous appendicitis was originally believed, at least in developed countries, to represent an isolated organ manifestation of Crohn’s disease; however, it is now recognised that Crohn’s disease accounts for only about 5–10% of granulomatous appendicitis [68] and that Crohn’s disease involving only the appendix is exceptional.
While previously a common diagnosis, idiopathic (primary) granulomatous appendicitis is in fact rare. Two aetiologies now account for the majority of these cases, namely, Yersinia infection and interval appendicectomy-related inflammation (see Fig. 7a, b) [68–70]. The relative contribution of interval appendectomy depends upon local surgical management but may represent more than half of all granulomas appendicitis cases encountered [70]. Other infections, mainly tuberculosis and parasitic infestations, are more commonly the cause of granulomatous appendicitis in tropical and subtropical countries. In a recent review of 13 cases drawn mainly from underdeveloped countries, infectious and non-infectious causes were responsible for 62 and 38% of granulomatous appendicitis, respectively [67]. Parasites were responsible for 38.5% of the cases [67]. Infrequent causes include sarcoidosis, fungal infection and foreign body reaction to impacted faeces [68].
The appendix can be normal sized or enlarged. An important histological feature is the number of granulomas which are more numerous with both idiopathic granulomatous appendicitis and infection, than with Crohn’s disease [71]. The latter may even be devoid of granulomas. The presence of necrosis in the granulomata should always suggest an infectious aetiology, while fistula or fissure formation is more common with Crohn’s disease [71, 72].
Other sites
Granulomata are uncommonly identified within the oesophagus. Partly, this is due to the fact mucosal biopsies do not include much submucosa. Crohn’s disease is the most common association in developed countries with the granulomata sitting just beneath the epithelium typically associated with a heavy chronic inflammatory cell infiltrate and lymphocytic oesophagitis pattern [7]. In our experience, an oesophageal biopsy that shows sub-epithelial chronic inflammation in a patient with high clinical suspicion of Crohn’s disease should be levelled even until the block is exhausted to identify a confirmatory granuloma. In countries with high prevalence of tuberculosis, this infection needs to be excluded since oesophageal involvement could represent either local infection or direct spread from the thoracic cavity.
Causes of granulomas in duodenum are similar to other sites in the intestine. The finding of ulceration, focal active chronic inflammation and granuloma formation is quite typical for Crohn’s disease in our experience [7]. These findings will almost universally be associated with other inflammatory change in the upper gastrointestinal tract particularly within the stomach.
Conclusion
Granulomata represent an occasionally identified inflammatory process within the gastrointestinal tract. Histopathologists play an important role in identifying the aetiology or providing clinical guidance as to the likely cause. In most cases, clinicopathological correlation is required to establish the final diagnosis.
References
Vinay Kumar, Abul K. Abbas and Jon C. Aster (2014) Chapter 3. Inflammation and repair. Robbins and Cotran pathologic basis of disease, 9th edition. Elsevier publishers. pp 96–97
Almadi MA, Aljebreen AM, Sanai FM et al (2011) New insights into gastrointestinal and hepatic granulomatous disorders. Nat Rev Gastroenterol Hepatol 8(8):455–466
Rotterdam H, Korelitz BI, Sommers SC (1977) Microgranulomas in grossly normal rectal mucosa in Crohn’s disease. Am J Clin Pathol 67:550–554
Molnár T, Tiszlavicz L, Gyulai C et al (2005) Clinical significance of granuloma in Crohn’s disease. World J Gastroenterol 11(20):3118–3121
Simillis C, Jacovides M, Reese GE et al (2010) Meta-analysis of the role of granulomas in the recurrence of Crohn’s disease. Dis Colon rectum 53(2):177–185
Heresbach D, Alexandre JL, Branger B et al (2005) Frequency and significance of granulomas in a cohort of incident cases of Crohn’s disease. Gut 54(2):215–222
Brown IS, Miller GC, Bettington ML, Rosty C (2016) Histopathological findings of extraileal manifestations at initial diagnosis of Crohn’s disease-related ileitis. Virchows Arch 469:515–522
Rubio CA, Orrego A, Nesi G, Finkel Y (2007) Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn’s colitis. J Clin Pathol 60(11):1268–1272
Mahadeva U, Martin JP, Patel NK, Price AB (2002) Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn’s disease from ulcerative colitis. Histopathology 41(1):50–55
Mooney EE, Walker J, Hourihane DO (1995) Relation of granulomas to lymphatic vessels in Crohn’s disease. J Clin Pathol 48(4):335–338
Wakefield AJ, Sankey EA, Dhillon AP et al (1991) Granulomatous vasculitis in Crohn’s disease. Gastroenterology 100(5 Pt 1):1279–1287
Lorenzi L, Bisoffi Z, Bortesi L et al (2012) Schaumann bodies in Crohn’s disease: a case report and review of the literature. J Crohn's Colitis 6(7):800–803
Almadi MA, Ghosh S, Aljebreen AM (2009) Differentiating intestinal tuberculosis from Crohn’s disease: a diagnostic challenge. Am J Gastroenterol 104(4):1003–1012
Thomson AB, Gupta M, Freeman HJ (2012) Use of the tumor necrosis factor-blockers for Crohn’s disease. World J Gastroenterol 18(35):4823–4854
Sood A, Midha V, Singh A (2014) Differential diagnosis of Crohn’s disease versus ileal tuberculosis. Curr Gastroenterol Rep 16(11):418
Pulimood AB, Ramakrishna BS, Kurian G et al (1999) Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis. Gut 45(4):537–541
Ye Z, Lin Y, Cao Q et al (2015) Granulomas as the most useful histopathological feature in distinguishing between Crohn’s disease and intestinal tuberculosis in endoscopic biopsy specimens. Medicine (Baltimore) 94(49):e2157
Makharia GK, Srivastava S, Das P et al (2010) Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am J Gastroenterol 105(3):642–651
Gan HT, Chen YQ, Ouyang Q et al (2002) Differentiation between intestinal tuberculosis and Crohn’s disease in endoscopic biopsy specimens by polymerase chain reaction. Am J Gastroenterol 97(6):1446–1451
Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 12:761–776
Holland SM (2013) Chronic granulomatous disease. Hematol Oncol Clin North Am 27(1):89–99
Alimchandani M, Lai JP, Aung PP et al (2013) Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol 9:1365–1372
Marks DJ, Miyagi K, Rahman FZ et al (2009) Inflammatory bowel disease in chronic granulomatous disease reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol 1:117–124
Hussain N, Quezado M, Huizing M et al (2006) Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype. Clin Gastroenterol Hepatol 1:73–80
Rose CD, Martin TM, Wouters CH (2011) Blau syndrome revisited. Curr Opin Rheumatol 5:411–418
Ghrenassia E, Mekinian A, Chapelon-Albric C et al (2016) Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases. Medicine (Baltimore) 95(29):e4279
Ebert EC, Kierson M, Hagspiel KD (2008) Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 12:3184–3192
Ellis H (1994) Pathological changes produced by surgical dusting powders. Ann R Coll Surg Engl 76(1):5–8
Carney JA, Stephens DH (1973) Intramural barium (barium granuloma) of colon and rectum. Gastroenterology 65(2):316–320
Hizawa K, Aoyagi K, Suekane H et al (1996) Suture granuloma in rectal anastomosis mistaken for locally recurrent cancer. J Clin Gastroenterol 23:78–79
Gupta A, Lyapichev K, Rojas CP (2016) Pulse granuloma of the rectum: an unusual entity. Histopathology 68(6):938–939
Nowacki NB, Arnold MA, Frankel WL et al (2015) Gastrointestinal tract-derived pulse granulomata: clues to an underrecognized pseudotumor. Am J Surg Pathol 39:84–92
Elbaz T, Esmat G (2013) Hepatic and intestinal schistosomiasis: review. J Adv Res 4(5):445–452
Sinniah B, Leopairut J, Neafie RC et al (1991) Enterobiasis: a histopathological study of 259 patients. Ann Trop Med Parasitol 85(6):625–635
Gutierrez Y, Bhatia P, Garbadawala ST et al (1996) Strongyloides stercoralis eosinophilic granulomatous enterocolitis. Am J Surg Pathol 20(5):603–612
Baert F, Hart J, Blackstone MO (1995) A case of diclofenac-induced colitis with focal granulomatous change. Am J Gastroenterol 90(10):1871–1873
Gonzalez RS, Salaria SN, Bohannon CD et al (2017) PD-1 inhibitor gastroenterocolitis: case series and appraisal of ‘immunomodulatory gastroenterocolitis’. Histopathology 70(4):558–567
Franco DL, Ruff K, Mertz L et al (2014) Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement. Case Rep Gastroenterol 8(3):329–336
Haworth S, Pusey C (1984) Severe intestinal involvement in Wegener’s granulomatosis. Gut 25:1296–1300
Skef W, Hamilton MJ, Arayssi T (2015) Gastrointestinal Behçet's disease: a review. World J Gastroenterol 21(13):3801–3812
Colombat M, Imbert A, Bruneval P et al (2001) Giant cell arteritis localized to the colon associated with Crohn’s disease. Histopathology 38(1):21–24
Daniels JA, Lederman HM, Maitra A, Montgomery EA (2007) Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 31(12):1800–1812
Gupta NK, Masia R (2013) Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract. Am J Surg Pathol 37(7):1109–1113
Lee FD, Maguire C, Obeidat W, Russell RI (1997) Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease. J Clin Pathol 50(2):148–152
Warren BF, Shepherd NA, Price AB, Williams GT (1997) Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease. J Clin Pathol 50(10):880–881
Yantiss RK, Odze RD (2006) Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology 48(2):116–132
Caso F, Galozzi P, Costa L, et al (2015) Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn’s disease. RMD Open. 20;1(1):e000097
Ectors NL, Dixon MF, Geboes KJ et al (1993) Granulomatous gastritis: a morphological and diagnostic approach. Histopathology 23:55
Maeng L, Lee A, Choi K et al (2004) Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol 28:941
Fahimi HD, Deren JI, Gottlieb LS, Zamcheck N (1963) Isolated granulomatous gastritis: its relationship to disseminated sarcoidosis and regional enteritis. Gastroenterology 45:161
Renault M, Goodier A, Subramony C et al (2010) Age-related differences in granulomatous gastritis: retrospective, clinicopathological analysis. J Clin Pathol 63(4):347–350
Kamani L, Mumtaz K, Azad NS, Jafri W (2008) Granulomatous gastritis: a diagnostic dilemma? Singap Med J 49:e222
Oberhuber G, Püspök A, Oesterreicher C et al (1997) Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease. Gastroenterology 112:698
Wright CL, Riddell RH (1998) Histology of the stomach and duodenum in Crohn’s disease. Am J Surg Pathol 22:383
Dhillon AP, Sawyerr A (1989) Granulomatous gastritis associated with Campylobacter pylori. APMIS 97(8):723–727
Ozturk Y, Buyukgebiz B, Ozer E et al (2004) Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy. J Pediatr Gastroenterol Nutr 39:286
Miyamoto M, Haruma K, Yoshihara M et al (2003) Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and helicobacter pylori. J Gastroenterol 38:371
Lauwers GY, Fujita H, Nagata K, Shimizu M (2010) Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol 45(2):131–145
Srivastava A, Lauwers GY (2007) Pathology of non-infective gastritis. Histopathology 50:15–29
Sève P, Stankovic K, Michalet V et al (2005) Carbimazole induced eosinophilic granulomatous vasculitis localized to the stomach. J Intern Med 258(2):191–195
Bojic D, Markovic S (2011) Terminal ileitis is not always Crohn’s disease. Ann Gastroenterol 24(4):271–275
Dilauro S, Crum-Cianflone NF (2010) Ileitis: when it is not Crohn’s disease. Curr Gastroenterol Rep 12(4):249–258
Goldstein NS, Leon-Armin C, Mani A (2000) Crohn’s colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn’s colitis. Am J Surg Pathol 24(5):668–675
Arnold CA, Limketkai BN, Illei PB et al (2013) Syphilitic and lymphogranuloma venereum (LGV) proctocolitis: clues to a frequently missed diagnosis. Am J Surg Pathol 37(1):38–46
Koreishi A, Lauwers GY, Misdraji J (2007) Pneumatosis intestinalis: a challenging biopsy diagnosis. Am J Surg Pathol 10:1469–1475
Lamps LW (2007) Infective disorders of the gastrointestinal tract. Histopathology 50:55–63
AbdullGaffar B (2010) Granulomatous diseases and granulomas of the appendix. Int J Surg Pathol 18(1):14–20
Bronner MP (2004) Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Semin Diagn Pathol 21:98–107
Lamps LW, Madhusudhan KT, Greenson JK et al (2001) The role of Yersinia enterocolitica and Yersinia pseudotuberculosis in granulomatous appendicitis: a histologic and molecular study. Am J Surg Pathol 25:508–515
Guo G, Greenson JK (2003) Histopathology of interval (delayed) appendectomy specimens: strong association with granulomatous and xanthogranulomatous appendicitis. Am J Surg Pathol 27:1147–1151
Dudley TH Jr, Dean PJ (1993) Idiopathic granulomatous appendicitis, or Crohn’s disease of the appendix revisited. Hum Pathol 24(6):595–601
Richards ML, Aberger FJ, Landercasper J (1997) Granulomatous appendicitis: Crohn’s disease, atypical Crohn’s or not Crohn’s at all? J Am Coll Surg 185:13–17
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This manuscript complies with local ethics guidelines.
Funding
No funding was required for this manuscript.
Conflict of interest
The authors state no conflicts of interest.
Rights and permissions
About this article
Cite this article
Brown, I., Kumarasinghe, M.P. Granulomas in the gastrointestinal tract: deciphering the Pandora’s box. Virchows Arch 472, 3–14 (2018). https://doi.org/10.1007/s00428-017-2210-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-017-2210-3